Synthesis of Gold Nanoparticles Using Cucurbitacin E-Glycoside and Methyl Gallate Isolated from Citrullus colocynthis L. Fruit and Evaluation of their Antibacterial and Antibiofilm Activities.
{"title":"Synthesis of Gold Nanoparticles Using Cucurbitacin E-Glycoside and Methyl Gallate Isolated from Citrullus colocynthis L. Fruit and Evaluation of their Antibacterial and Antibiofilm Activities.","authors":"Achyut Adhikari, Asmita Sapkota, Syed Muhammad Zaki Shah, Kapil Aryal, Prajwal Acharya","doi":"10.2174/0122117385314421241009075737","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Metal nanoparticles have received much attention due to their unique physical dynamics, chemical reactivity, and promising biological applications. Green synthesis using natural compounds is an alternative to traditional chemical methods for the synthesis of nanoparticles.</p><p><strong>Materials and methods: </strong>Herein, two secondary metabolites were isolated from different fractions of methanolic extract of Citrullus colocynthis (bitter apple) Schard. and identified as cucurbitacin Eglycoside (1) and methyl gallate (2). Both compounds were used in the green nanoformulation of gold nanoparticles. Mass spectrometry and NMR spectroscopy were used for structure elucidation of compound 1 and compound 2. UV-vis spectroscopy, FTIR, and AFM were performed to confirm the formation of AuNPs.</p><p><strong>Result and discussions: </strong>The spectra of UV-Vis showed a characteristic peak at 519 nm and 548 nm for compounds 1 and 2, respectively. AuNPs ranged mostly between 1 and 50 nm measured using AFM. The FTIR analysis confirmed the presence of phytochemicals on the surface of AuNPs. The synthesized AuNPs showed good antibacterial activity against Escherichia coli, Bacillus subtilis, and Pseudomonas aeruginosa.</p><p><strong>Conclusion: </strong>The synthesized AuNPs demonstrated good antibiofilm activity against Streptococcus mutans. Thus, the green synthesized AuNPs can combat the pathogenicity of several human pathogens.</p>","PeriodicalId":19774,"journal":{"name":"Pharmaceutical nanotechnology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical nanotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0122117385314421241009075737","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Metal nanoparticles have received much attention due to their unique physical dynamics, chemical reactivity, and promising biological applications. Green synthesis using natural compounds is an alternative to traditional chemical methods for the synthesis of nanoparticles.
Materials and methods: Herein, two secondary metabolites were isolated from different fractions of methanolic extract of Citrullus colocynthis (bitter apple) Schard. and identified as cucurbitacin Eglycoside (1) and methyl gallate (2). Both compounds were used in the green nanoformulation of gold nanoparticles. Mass spectrometry and NMR spectroscopy were used for structure elucidation of compound 1 and compound 2. UV-vis spectroscopy, FTIR, and AFM were performed to confirm the formation of AuNPs.
Result and discussions: The spectra of UV-Vis showed a characteristic peak at 519 nm and 548 nm for compounds 1 and 2, respectively. AuNPs ranged mostly between 1 and 50 nm measured using AFM. The FTIR analysis confirmed the presence of phytochemicals on the surface of AuNPs. The synthesized AuNPs showed good antibacterial activity against Escherichia coli, Bacillus subtilis, and Pseudomonas aeruginosa.
Conclusion: The synthesized AuNPs demonstrated good antibiofilm activity against Streptococcus mutans. Thus, the green synthesized AuNPs can combat the pathogenicity of several human pathogens.
期刊介绍:
Pharmaceutical Nanotechnology publishes original manuscripts, full-length/mini reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of materials at the nanoscale. The nanoscale is defined as a size range of below 1 µm. Scientific findings related to micro and macro systems with functionality residing within features defined at the nanoscale are also within the scope of the journal. Manuscripts detailing the synthesis, exhaustive characterisation, biological evaluation, clinical testing and/ or toxicological assessment of nanomaterials are of particular interest to the journal’s readership. Articles should be self contained, centred around a well founded hypothesis and should aim to showcase the pharmaceutical/ diagnostic implications of the nanotechnology approach. Manuscripts should aim, wherever possible, to demonstrate the in vivo impact of any nanotechnological intervention. As reducing a material to the nanoscale is capable of fundamentally altering the material’s properties, the journal’s readership is particularly interested in new characterisation techniques and the advanced properties that originate from this size reduction. Both bottom up and top down approaches to the realisation of nanomaterials lie within the scope of the journal.